These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 12556576)
21. Cerebral blood flow and metabolic abnormalities in Alzheimer's disease. Matsuda H Ann Nucl Med; 2001 Apr; 15(2):85-92. PubMed ID: 11448080 [TBL] [Abstract][Full Text] [Related]
22. SPECT and MRI analysis in Alzheimer's disease: relation to apolipoprotein E epsilon 4 allele. Lehtovirta M; Soininen H; Laakso MP; Partanen K; Helisalmi S; Mannermaa A; Ryynänen M; Kuikka J; Hartikainen P; Riekkinen PJ J Neurol Neurosurg Psychiatry; 1996 Jun; 60(6):644-9. PubMed ID: 8648331 [TBL] [Abstract][Full Text] [Related]
23. Insulin effects on glucose metabolism, memory, and plasma amyloid precursor protein in Alzheimer's disease differ according to apolipoprotein-E genotype. Craft S; Asthana S; Schellenberg G; Baker L; Cherrier M; Boyt AA; Martins RN; Raskind M; Peskind E; Plymate S Ann N Y Acad Sci; 2000 Apr; 903():222-8. PubMed ID: 10818510 [TBL] [Abstract][Full Text] [Related]
24. Lack of an association between apolipoprotein E epsilon 4 and Alzheimer's disease in elderly Nigerians. Osuntokun BO; Sahota A; Ogunniyi AO; Gureje O; Baiyewu O; Adeyinka A; Oluwole SO; Komolafe O; Hall KS; Unverzagt FW Ann Neurol; 1995 Sep; 38(3):463-5. PubMed ID: 7668835 [TBL] [Abstract][Full Text] [Related]
25. Apolipoprotein E alleles and brain vascular pathology in Alzheimer's disease. Kalaria RN; Cohen DL; Premkumar DR Ann N Y Acad Sci; 1996 Jan; 777():266-70. PubMed ID: 8624096 [TBL] [Abstract][Full Text] [Related]
26. Combined effect of apolipoprotein e genotype and past fertility on age at onset of Alzheimer's disease in women. Corbo RM; Gambina G; Ulizzi L; Monini P; Broggio E; Rosano A; Scacchi R Dement Geriatr Cogn Disord; 2007; 24(2):82-5. PubMed ID: 17565217 [TBL] [Abstract][Full Text] [Related]
27. Allele doses of apolipoprotein E type epsilon 4 in sporadic late-onset Alzheimer's disease. Lucotte G; Aouizérate A; Gérard N; Turpin JC; Landais P Am J Med Genet; 1995 Dec; 60(6):566-9. PubMed ID: 8825898 [TBL] [Abstract][Full Text] [Related]
28. High frequency of apolipoprotein E epsilon 2 allele in hemorrhage due to cerebral amyloid angiopathy. Nicoll JA; Burnett C; Love S; Graham DI; Dewar D; Ironside JW; Stewart J; Vinters HV Ann Neurol; 1997 Jun; 41(6):716-21. PubMed ID: 9189032 [TBL] [Abstract][Full Text] [Related]
29. Distribution of apolipoprotein E4 isoform in Alzheimer's disease in Poland. Bratosiewicz-Zapart J; Kłoszewska I; Sobów T; Liberski PP Arch Immunol Ther Exp (Warsz); 1997; 45(2-3):221-2. PubMed ID: 9597090 [TBL] [Abstract][Full Text] [Related]
30. Lack of effect of apolipoprotein E E4 allele on neuropsychiatric manifestations in Alzheimer's disease. Hirono N; Mori E; Yasuda M; Imamura T; Shimomura T; Hashimoto M; Tanimukai S; Kazui H; Yamashita H J Neuropsychiatry Clin Neurosci; 1999; 11(1):66-70. PubMed ID: 9990558 [TBL] [Abstract][Full Text] [Related]
31. Prediction of individual clinical outcome in MCI by means of genetic assessment and (18)F-FDG PET. Drzezga A; Grimmer T; Riemenschneider M; Lautenschlager N; Siebner H; Alexopoulus P; Minoshima S; Schwaiger M; Kurz A J Nucl Med; 2005 Oct; 46(10):1625-32. PubMed ID: 16204712 [TBL] [Abstract][Full Text] [Related]
32. Rhinal hypometabolism on FDG PET in healthy APO-E4 carriers: impact on memory function and metabolic networks. Didic M; Felician O; Gour N; Bernard R; Pécheux C; Mundler O; Ceccaldi M; Guedj E Eur J Nucl Med Mol Imaging; 2015 Sep; 42(10):1512-21. PubMed ID: 25900275 [TBL] [Abstract][Full Text] [Related]
33. APOE-epsilon4 is associated with less frontal and more medial temporal lobe atrophy in AD. Geroldi C; Pihlajamäki M; Laakso MP; DeCarli C; Beltramello A; Bianchetti A; Soininen H; Trabucchi M; Frisoni GB Neurology; 1999 Nov; 53(8):1825-32. PubMed ID: 10563634 [TBL] [Abstract][Full Text] [Related]
34. Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease. Reiman EM; Caselli RJ; Chen K; Alexander GE; Bandy D; Frost J Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3334-9. PubMed ID: 11248079 [TBL] [Abstract][Full Text] [Related]
35. Apolipoprotein E genotype in patients with Alzheimer's disease: implications for the risk of dementia among relatives. Farrer LA; Cupples LA; van Duijn CM; Kurz A; Zimmer R; Müller U; Green RC; Clarke V; Shoffner J; Wallace DC Ann Neurol; 1995 Nov; 38(5):797-808. PubMed ID: 7486872 [TBL] [Abstract][Full Text] [Related]
36. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia. Reiman EM; Chen K; Alexander GE; Caselli RJ; Bandy D; Osborne D; Saunders AM; Hardy J Proc Natl Acad Sci U S A; 2004 Jan; 101(1):284-9. PubMed ID: 14688411 [TBL] [Abstract][Full Text] [Related]
37. Apolipoprotein E epsilon 4 allele and whole brain atrophy in late-onset Alzheimer's disease. Yasuda M; Mori E; Kitagaki H; Yamashita H; Hirono N; Shimada K; Maeda K; Tanaka C Am J Psychiatry; 1998 Jun; 155(6):779-84. PubMed ID: 9619150 [TBL] [Abstract][Full Text] [Related]
38. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele. Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251 [TBL] [Abstract][Full Text] [Related]
39. APOE-related biomarker profiles in non-pathological aging and early phases of Alzheimer's disease. Reinvang I; Espeseth T; Westlye LT Neurosci Biobehav Rev; 2013 Sep; 37(8):1322-35. PubMed ID: 23701948 [TBL] [Abstract][Full Text] [Related]
40. [Apolipoprotein E 4 gene is a risk factor for Alzheimer's disease]. Peng D; Xu X; Feng Y Zhonghua Nei Ke Za Zhi; 2001 Oct; 40(10):688-90. PubMed ID: 11769724 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]